This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid014I It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid014I.html Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine. The full table of all monthly collections is: at house-of-papers.com PMC searches were done at moremed.org
PMC7346263 1. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
PMC7380217 13. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
PMC7334636 26. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
40. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.
PMC7373679 60. Lymphocyte subsets with the lowest decline at baselineand the slow lowest rise during recovery in COVID-19 critical illnesspatients with diabetes mellitus.
PMC7378008 67. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.
PMC7374176 68. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
{{tp|p=32656452|t=2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.|pdf=|usr=}} {{tp|p=32712145|t=2020. Multisystem inflammatory syndrome with particular cutaneous lesions related to COVID 19 in a young adult.|pdf=|usr=}} {{tp|p=32659225|t=2020. The role of a cytokine storm in severe COVID-19 disease in pregnancy.|pdf=|usr=}} {{tp|p=32701539|t=2020. HLA-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection.|pdf=|usr=}} {{tp|p=32659620|t=2020. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.|pdf=|usr=}} {{tp|p=32653819|t=2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.|pdf=|usr=}} {{tp|p=32676824|t=2020. Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study.|pdf=|usr=}} {{tp|p=32708525|t=2020. From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry.|pdf=|usr=}} {{tp|p=32669265|t=2020. Discovery of M Protease inhibitors encoded by SARS-CoV-2.|pdf=|usr=}} {{tp|p=32708430|t=2020. Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm.|pdf=|usr=}} {{tp|p=32653765|t=2020. Immunosenescence exacerbates the COVID-19.|pdf=|usr=}} {{tp|p=32651741|t=2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.|pdf=|usr=}} {{tp|p=32717432|t=2020. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.|pdf=|usr=}} {{tp|p=32685484|t=2020. Identification of COVID-19 Infection-Related Human Genes Based on a Random Walk Model in a Virus-Human Protein Interaction Network.|pdf=|usr=}} {{tp|p=32664932|t=2020. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?|pdf=|usr=}} {{tp|p=32664879|t=2020. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.|pdf=|usr=}} {{tp|p=32665075|t=2020. Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19.|pdf=|usr=}} {{tp|p=32708264|t=2020. Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19.|pdf=|usr=}} {{tp|p=32645325|t=2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.|pdf=|usr=}} {{tp|p=32697970|t=2020. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.|pdf=|usr=}} {{tp|p=32697968|t=2020. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.|pdf=|usr=}} {{tp|p=32673567|t=2020. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.|pdf=|usr=}} {{tp|p=32690996|t=2020. COVID-19 infection: mitohormetic concept of immune response.|pdf=|usr=}} {{tp|p=32697943|t=2020. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.|pdf=|usr=}} {{tp|p=32612152|t=2020. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.|pdf=|usr=}} {{tp|p=32623480|t=2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.|pdf=|usr=}} {{tp|p=32712910|t=2020. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.|pdf=|usr=}} {{tp|p=32623546|t=2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.|pdf=|usr=}} {{tp|p=32668215|t=2020. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.|pdf=|usr=}} {{tp|p=32632255|t=2020. Pulmonary alveolar regeneration in adult COVID-19 patients.|pdf=|usr=}} {{tp|p=32612199|t=2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.|pdf=|usr=}} {{tp|p=32673562|t=2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.|pdf=|usr=}} {{tp|p=32619549|t=2020. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.|pdf=|usr=}} {{tp|p=32660065|t=2020. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.|pdf=|usr=}} {{tp|p=32635598|t=2020. Canonical and Noncanonical Autophagy as Potential Targets for COVID-19.|pdf=|usr=}} {{tp|p=32707842|t=2020. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes.|pdf=|usr=}} {{tp|p=32622823|t=2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.|pdf=|usr=}} {{tp|p=32707182|t=2020. Novel Temperature Trajectory Subphenotypes in COVID-19.|pdf=|usr=}} {{tp|p=32622819|t=2020. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.|pdf=|usr=}} {{tp|p=32630212|t=2020. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.|pdf=|usr=}} {{tp|p=32700055|t=2020. The extended autonomic system, dyshomeostasis, and COVID-19.|pdf=|usr=}} {{tp|p=32671502|t=2020. Is 'happy hypoxia' in COVID-19 a disorder of autonomic interoception? A hypothesis.|pdf=|usr=}} {{tp|p=32661775|t=2020. Testing cardiovascular autonomic function in the COVID-19 era: lessons from Bologna's Autonomic Unit.|pdf=|usr=}} {{tp|p=32673668|t=2020. Insights into pediatric multi-system inflammatory syndrome and COVID-19.|pdf=|usr=}} {{tp|p=32683814|t=2020. Can we get a clue for the etiology of Kawasaki disease in the COVID-19 pandemic?|pdf=|usr=}} {{tp|p=32664709|t=2020. Immunopathogenesis of COVID-19 and early immunomodulators.|pdf=|usr=}} {{tp|p=32712394|t=2020. Letter to the Editor: Lessons from COVID-19, ACE2 and intestinal inflammation - could a virus trigger chronic intestinal inflammation?|pdf=|usr=}} {{tp|p=32659373|t=2020. Long-term infection of SARS-CoV-2 changed the body's immune status.|pdf=|usr=}} {{tp|p=32653662|t=2020. Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.|pdf=|usr=}} {{tp|p=32653658|t=2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.|pdf=|usr=}} {{tp|p=32717416|t=2020. Evolution of viral quasispecies during SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32711057|t=2020. Viable SARS-CoV-2 in various specimens from COVID-19 patients.|pdf=|usr=}} {{tp|p=32688067|t=2020. Body temperature and host species preferences of SARS-CoV-2.|pdf=|usr=}} {{tp|p=32658736|t=2020. Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans.|pdf=|usr=}} {{tp|p=32709253|t=2020. Response to "Body temperature correlates with mortality in COVID-19 patients".|pdf=|usr=}} {{tp|p=32698857|t=2020. Could the severity of COVID-19 be increased by low gastric acidity?|pdf=|usr=}} {{tp|p=32690058|t=2020. Detection of IgG antibody during the follow-up in patients with COVID-19 infection.|pdf=|usr=}} {{tp|p=32711241|t=2020. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.|pdf=|usr=}} {{tp|p=32685628|t=2020. Haematological and immunological data of Chinese children infected with coronavirus disease 2019.|pdf=|usr=}} {{tp|p=32707212|t=2020. Lymphocyte subsets with the lowest decline at baselineand the slow lowest rise during recovery in COVID-19 critical illnesspatients with diabetes mellitus.|pdf=|usr=}} {{tp|p=32665025|t=2020. The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2.|pdf=|usr=}} {{tp|p=32699547|t=2020. Kawasaki disease in siblings and a review of drug treatment.|pdf=|usr=}} {{tp|p=32711256|t=2020. Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis.|pdf=|usr=}} {{tp|p=32711254|t=2020. Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity.|pdf=|usr=}} {{tp|p=32707445|t=2020. Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections.|pdf=|usr=}} {{tp|p=32717182|t=2020. Lessons for COVID-19 Immunity from Other Coronavirus Infections.|pdf=|usr=}} {{tp|p=32712315|t=2020. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.|pdf=|usr=}} {{tp|p=32707288|t=2020. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.|pdf=|usr=}}
80. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 1.
87. ACE2, the Receptor that Enables the Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators.
103. TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2.
{{tp|p=32668462|t=2020. COVID-19: An Immunopathologic Assault.|pdf=|usr=}} {{tp|p=32709193|t=2020. Lung Injury in COVID-19-An Emerging Hypothesis.|pdf=|usr=}} {{tp|p=32673476|t=2020. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism.|pdf=|usr=}} {{tp|p=32672403|t=2020. microRNAs as new possible actors in gender disparities of Covid-19 pandemic.|pdf=|usr=}} {{tp|p=32662161|t=2020. Covid-19, ACE2, and the kidney.|pdf=|usr=}} {{tp|p=32681166|t=2020. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.|pdf=|usr=}} {{tp|p=32666092|t=2020. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.|pdf=|usr=}} {{tp|p=32662111|t=2020. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes.|pdf=|usr=}} {{tp|p=32706609|t=2020. Inducible Epithelial Resistance Against Coronavirus Pneumonia in Mice.|pdf=|usr=}} {{tp|p=32663409|t=2020. Single-cell RNA Expression Profiling of ACE2, The Receptor of SARS-CoV-2.|pdf=|usr=}} {{tp|p=32662396|t=2020. Temporal Change of SARS-CoV-2 in Clinical Specimens of COVID-19 Pneumonia Patients.|pdf=|usr=}} {{tp|p=32705809|t=2020. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 1.|pdf=|usr=}} {{tp|p=32716641|t=2020. Coronavirus Optimization Algorithm: A Bioinspired Metaheuristic Based on the COVID-19 Propagation Model.|pdf=|usr=}} {{tp|p=32686774|t=2020. Multiple sclerosis and COVID-19.|pdf=|usr=}} {{tp|p=32654296|t=2020. A Tale of (Glycogen Synthase Kinase) Three: Lithium, The Kidney and Coronavirus Disease 19.|pdf=|usr=}} {{tp|p=32679621|t=2020. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.|pdf=|usr=}} {{tp|p=32678953|t=2020. Clinical characteristics, management and outcome of Covid-19-associated immune thrombocytopenia. A French multicenter series.|pdf=|usr=}} {{tp|p=32678950|t=2020. Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients.|pdf=|usr=}} {{tp|p=32663362|t=2020. ACE2, the Receptor that Enables the Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators.|pdf=|usr=}} {{tp|p=32654514|t=2020. Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-mediated Effects on Potassium Channel Expression.|pdf=|usr=}} {{tp|p=32689809|t=2020. Unexpected Features of Cardiac Pathology in COVID-19 Infection.|pdf=|usr=}} {{tp|p=32706417|t=2020. Characteristics and roles of SARS-CoV-2 specific antibodies in patients with different severities of COVID-19.|pdf=|usr=}} {{tp|p=32717055|t=2020. Diagnosing SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium.|pdf=|usr=}} {{tp|p=32710613|t=2020. Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain.|pdf=|usr=}} {{tp|p=32672790|t=2020. Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients.|pdf=|usr=}} {{tp|p=32667973|t=2020. SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters.|pdf=|usr=}} {{tp|p=32663256|t=2020. Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity.|pdf=|usr=}} {{tp|p=32694169|t=2020. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?|pdf=|usr=}} {{tp|p=32713339|t=2020. Viral Evolution will Automatically Resolve COVID-19 Pandemic.|pdf=|usr=}} {{tp|p=32660402|t=2020. NPC1 as a Modulator of Disease Severity and Viral Entry of Sars-CoV-2.|pdf=|usr=}} {{tp|p=32657802|t=2020. Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: menage a trois.|pdf=|usr=}} {{tp|p=32675718|t=2020. Reflections on rheumatological aspects of COVID-19.|pdf=|usr=}} {{tp|p=32654350|t=2020. Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32662099|t=2020. Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus-2 proteome.|pdf=|usr=}} {{tp|p=32657473|t=2020. TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2.|pdf=|usr=}} {{tp|p=32652001|t=2020. Endocrine significance of SARS-CoV-2's reliance on ACE2.|pdf=|usr=}} {{tp|p=32686577|t=2020. Epigenetic mechanisms regulating COVID-19 infection.|pdf=|usr=}} {{tp|p=32710612|t=2020. Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2.|pdf=|usr=}} {{tp|p=32643968|t=2020. Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress.|pdf=|usr=}} {{tp|p=32706090|t=2020. CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients.|pdf=|usr=}} {{tp|p=32692465|t=2020. COVID-19, Cilia, and Smell.|pdf=|usr=}} {{tp|p=32692408|t=2020. Third Trimester Placentas of SARS-CoV-2-Positive Women: Histomorphology, including Viral Immunohistochemistry and in Situ Hybridization.|pdf=|usr=}} {{tp|p=32678695|t=2020. Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development.|pdf=|usr=}} {{tp|p=32689852|t=2020. Immune Responses to the Novel Coronavirus-2: Friend or Foe?|pdf=|usr=}}
PMC7367681 113. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?
PMC7333770 119. "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-gamma, IL-17A, and a Janus Kinase Inhibitor.
PMC7324317 125. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
PMC7351063 126. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response.
130. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
PMC7360123 134. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply.
PMC7340597 142. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.
PMC7372174 145. ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.
PMC7342089 146. Oscillation of SARS CoV-2 RNA load in a cohort of children and adolescents with neuro-psychiatric disorders resident in a nursing home of Lombardy Region (Italy).
PMC7347350 157. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.
PMC7368418 159. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.
PMC7367812 160. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
PMC7340217 169. Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure.
{{tp|p=32662421|t=2020. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?|pdf=|usr=}} {{tp|p=32665942|t=2020. Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.|pdf=|usr=}} {{tp|p=32675207|t=2020. Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects.|pdf=|usr=}} {{tp|p=32675206|t=2020. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue.|pdf=|usr=}} {{tp|p=32703822|t=2020. Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge.|pdf=|usr=}} {{tp|p=32714336|t=2020. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.|pdf=|usr=}} {{tp|p=32676080|t=2020. "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-gamma, IL-17A, and a Janus Kinase Inhibitor.|pdf=|usr=}} {{tp|p=32670298|t=2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.|pdf=|usr=}} {{tp|p=32695025|t=2020. Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host.|pdf=|usr=}} {{tp|p=32676039|t=2020. COVID-19 Sepsis and Microcirculation Dysfunction.|pdf=|usr=}} {{tp|p=32658591|t=2020. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.|pdf=|usr=}} {{tp|p=32682765|t=2020. Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19.|pdf=|usr=}} {{tp|p=32668194|t=2020. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.|pdf=|usr=}} {{tp|p=32659267|t=2020. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response.|pdf=|usr=}} {{tp|p=32683337|t=2020. Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19.|pdf=|usr=}} {{tp|p=32683336|t=2020. Hyperinflammatory Syndrome in Children Associated with COVID-19: Need for Awareness.|pdf=|usr=}} {{tp|p=32659347|t=2020. Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.|pdf=|usr=}} {{tp|p=32708334|t=2020. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.|pdf=|usr=}} {{tp|p=32668803|t=2020. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.|pdf=|usr=}} {{tp|p=32664543|t=2020. Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation.|pdf=|usr=}} {{tp|p=32681297|t=2020. Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?|pdf=|usr=}} {{tp|p=32666177|t=2020. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply.|pdf=|usr=}} {{tp|p=32695405|t=2020. COVID-19 and cryo-EM.|pdf=|usr=}} {{tp|p=32675285|t=2020. Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease.|pdf=|usr=}} {{tp|p=32701511|t=2020. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children.|pdf=|usr=}} {{tp|p=32708872|t=2020. Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients.|pdf=|usr=}} {{tp|p=32674356|t=2020. Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells.|pdf=|usr=}} {{tp|p=32690544|t=2020. Genetic variations in the human severe acute respiratory syndrome coronavirus receptor ACE2 and serine protease TMPRSS2.|pdf=|usr=}} {{tp|p=32707511|t=2020. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.|pdf=|usr=}} {{tp|p=32674001|t=2020. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.|pdf=|usr=}} {{tp|p=32652214|t=2020. Factors affecting stability and infectivity of SARS-CoV-2.|pdf=|usr=}} {{tp|p=32699345|t=2020. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.|pdf=|usr=}} {{tp|p=32675312|t=2020. ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.|pdf=|usr=}} {{tp|p=32652168|t=2020. Oscillation of SARS CoV-2 RNA load in a cohort of children and adolescents with neuro-psychiatric disorders resident in a nursing home of Lombardy Region (Italy).|pdf=|usr=}} {{tp|p=32718895|t=2020. Immune response in COVID-19: A review.|pdf=|usr=}} {{tp|p=32707537|t=2020. Hazards of the cytokine storm and cytokine-targeted therapy in COVID-19 patients: A Review.|pdf=|usr=}} {{tp|p=32627759|t=2020. An Overview of the Genetic Variations of the SARS-CoV-2 Genomes Isolated in Southeast Asian Countries.|pdf=|usr=}} {{tp|p=32710986|t=2020. Mutations Strengthened SARS-CoV-2 Infectivity.|pdf=|usr=}} {{tp|p=32717229|t=2020. Epidemiological trends in Kawasaki disease during COVID-19 in Singapore.|pdf=|usr=}} {{tp|p=32661139|t=2020. Broad and differential animal ACE2 receptor usage by SARS-CoV-2.|pdf=|usr=}} {{tp|p=32706339|t=2020. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.|pdf=|usr=}} {{tp|p=32687484|t=2020. Severe immunosuppression and not a cytokine storm characterize COVID-19 infections.|pdf=|usr=}} {{tp|p=32659211|t=2020. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.|pdf=|usr=}} {{tp|p=32682491|t=2020. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.|pdf=|usr=}} {{tp|p=32653054|t=2020. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.|pdf=|usr=}} {{tp|p=32653518|t=2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.|pdf=|usr=}} {{tp|p=32693241|t=2020. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.|pdf=|usr=}} {{tp|p=32687918|t=2020. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.|pdf=|usr=}} {{tp|p=32703818|t=2020. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.|pdf=|usr=}} {{tp|p=32694143|t=2020. Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2.|pdf=|usr=}} {{tp|p=32679426|t=2020. The <> able to explain the Th1 immune lockdown in severe COVID-19.|pdf=|usr=}} {{tp|p=32679424|t=2020. Natural protection of ocular surface from viral infections - A hypothesis.|pdf=|usr=}} {{tp|p=32673940|t=2020. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.|pdf=|usr=}} {{tp|p=32683222|t=2020. The immunomodulatory effects of exercise against COVID-19.|pdf=|usr=}} {{tp|p=32679425|t=2020. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.|pdf=|usr=}} {{tp|p=32664116|t=2020. Late histological findings in symptomatic COVID-19 patients: A case report.|pdf=|usr=}} {{tp|p=32670525|t=2020. Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure.|pdf=|usr=}} {{tp|p=32670517|t=2020. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.|pdf=|usr=}} {{tp|p=32653475|t=2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?|pdf=|usr=}} {{tp|p=32710269|t=2020. Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.|pdf=|usr=}} {{tp|p=32709887|t=2020. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.|pdf=|usr=}} {{tp|p=32709886|t=2020. Structural basis of RNA cap modification by SARS-CoV-2.|pdf=|usr=}} {{tp|p=32708840|t=2020. Genetic Diversity Among SARS-CoV2 Strains in South America may Impact Performance of Molecular Detection.|pdf=|usr=}}
{{tp|p=32672799|t=2020. Eosinopenia and COVID-19.|pdf=|usr=}} {{tp|p=32680910|t=2020. Kidney Biopsy Findings in Patients with COVID-19.|pdf=|usr=}} {{tp|p=32675304|t=2020. Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19.|pdf=|usr=}} {{tp|p=32669323|t=2020. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.|pdf=|usr=}} {{tp|p=32660970|t=2020. COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.|pdf=|usr=}} {{tp|p=32651224|t=2020. Caution in Identifying Coronaviruses by Electron Microscopy.|pdf=|usr=}} {{tp|p=32700513|t=2020. Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?|pdf=|usr=}} {{tp|p=32660959|t=2020. Is FURIN gene expression in salivary glands related to SARS-CoV-2 infectivity through saliva?|pdf=|usr=}} {{tp|p=32667280|t=2020. A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.|pdf=|usr=}} {{tp|p=32699160|t=2020. COVID-19: Complement, Coagulation, and Collateral Damage.|pdf=|usr=}} {{tp|p=32696489|t=2020. Cytokine storm syndrome in coronavirus disease 2019: A narrative review.|pdf=|usr=}} {{tp|p=32716059|t=2020. Response to Comment on "Genetic Variants and Source of Introduction of SARS-CoV-2 in South America".|pdf=|usr=}} {{tp|p=32710647|t=2020. Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen.|pdf=|usr=}} {{tp|p=32706425|t=2020. The dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19.|pdf=|usr=}} {{tp|p=32706420|t=2020. Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.|pdf=|usr=}} {{tp|p=32706410|t=2020. SARS-CoV-2 Causes Kawasaki like Disease in children; Cases reported in Pakistan.|pdf=|usr=}} {{tp|p=32706407|t=2020. SARS-Cov-2 infection causes pulmonary shunt by vasodilatation.|pdf=|usr=}} {{tp|p=32681651|t=2020. COVID-19: What type of cytokine storm are we dealing with?|pdf=|usr=}} {{tp|p=32699095|t=2020. Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.|pdf=|usr=}} {{tp|p=32679087|t=2020. COVID-19: from rapid genome sequencing to fast decisions.|pdf=|usr=}} {{tp|p=32654359|t=2020. Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations.|pdf=|usr=}} {{tp|p=32687176|t=2020. Evidence for strong mutation bias towards, and selection against, U content in SARS-CoV-2: implications for vaccine design.|pdf=|usr=}} {{tp|p=32706959|t=2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.|pdf=|usr=}} {{tp|p=32706954|t=2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.|pdf=|usr=}} {{tp|p=32678534|t=2020. Pulmonary Vascular Pathology in Covid-19. Reply.|pdf=|usr=}} {{tp|p=32678533|t=2020. Pulmonary Vascular Pathology in Covid-19.|pdf=|usr=}} {{tp|p=32678532|t=2020. Pulmonary Vascular Pathology in Covid-19.|pdf=|usr=}} {{tp|p=32678531|t=2020. Pulmonary Vascular Pathology in Covid-19.|pdf=|usr=}} {{tp|p=32719485|t=2020. Sampling the host response to SARS-CoV-2 in hospitals under siege.|pdf=|usr=}} {{tp|p=32661393|t=2020. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.|pdf=|usr=}} {{tp|p=32704094|t=2020. LY6E impairs coronavirus fusion and confers immune control of viral disease.|pdf=|usr=}} {{tp|p=32669681|t=2020. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.|pdf=|usr=}} {{tp|p=32717743|t=2020. Longitudinal analyses reveal immunological misfiring in severe COVID-19.|pdf=|usr=}} {{tp|p=32668444|t=2020. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.|pdf=|usr=}} {{tp|p=32659783|t=2020. A perspective on potential antibody-dependent enhancement of SARS-CoV-2.|pdf=|usr=}} {{tp|p=32661414|t=2020. A race to determine what drives COVID-19 severity.|pdf=|usr=}} {{tp|p=32684080|t=2020. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.|pdf=|usr=}} {{tp|p=32659199|t=2020. COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?|pdf=|usr=}} {{tp|p=32654247|t=2020. Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.|pdf=|usr=}} {{tp|p=32672025|t=2020. Immunite cellulaire contre SARS-CoV-2 : substrat de l'immunite croisee entre coronavirus saisonniers et SARS-CoV-2 ?|pdf=|usr=}} {{tp|p=32686248|t=2020. Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body.|pdf=|usr=}} {{tp|p=32671966|t=2020. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.|pdf=|usr=}} {{tp|p=32656939|t=2020. Lessons from dermatology about inflammatory responses in Covid-19.|pdf=|usr=}} {{tp|p=32668509|t=2020. Variabilidad genetica y epigenetica, y la pandemia de Covid-19.|pdf=|usr=}} {{tp|p=32697854|t=2020. Interferon: the invisible link between COVID-19 and BCGitis female protection?|pdf=|usr=}} {{tp|p=32697367|t=2020. inverted question markAre Superantigens the Cause of Cytokine Storm and viral sepsis in Severe COVID-19? Observations and hypothesis.|pdf=|usr=}} {{tp|p=32680954|t=2020. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.|pdf=|usr=}} {{tp|p=32669287|t=2020. Comprehensive mapping of immune perturbations associated with severe COVID-19.|pdf=|usr=}} {{tp|p=32651212|t=2020. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.|pdf=|usr=}}
225. SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders.
PMC7372545 227. Comments to: A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression.
PMC7348599 245. Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.
PMC7370872 252. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45(-) Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.
{{tp|p=32679910|t=2020. SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders.|pdf=|usr=}} {{tp|p=32678072|t=2020. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.|pdf=|usr=}} {{tp|p=32694615|t=2020. Comments to: A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression.|pdf=|usr=}} {{tp|p=32715628|t=2020. Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19?|pdf=|usr=}} {{tp|p=32715618|t=2020. The protein expression profile of ACE2 in human tissues.|pdf=|usr=}} {{tp|p=32669467|t=2020. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.|pdf=|usr=}} {{tp|p=32694127|t=2020. COVID-19 and the Gut Microbiome: More than a Gut Feeling.|pdf=|usr=}} {{tp|p=32681106|t=2020. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.|pdf=|usr=}} {{tp|p=32665645|t=2020. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.|pdf=|usr=}} {{tp|p=32686754|t=2020. Antibody responses to SARS-CoV-2 short-lived.|pdf=|usr=}} {{tp|p=32686753|t=2020. Virus dissociated from inflammation in fatal COVID-19.|pdf=|usr=}} {{tp|p=32651570|t=2020. CRISPRing for host genes regulating SARS-CoV-2.|pdf=|usr=}} {{tp|p=32651569|t=2020. SARS-CoV-2 on the neural battleground.|pdf=|usr=}} {{tp|p=32651568|t=2020. T cell renaissance in COVID-19.|pdf=|usr=}} {{tp|p=32690876|t=2020. Can COVID-19 strike twice?|pdf=|usr=}} {{tp|p=32699357|t=2020. COVID-19 management in light of the circadian clock.|pdf=|usr=}} {{tp|p=32668692|t=2020. Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA.|pdf=|usr=}} {{tp|p=32691391|t=2020. Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology.|pdf=|usr=}} {{tp|p=32665786|t=2020. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.|pdf=|usr=}} {{tp|p=32685291|t=2020. Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure.|pdf=|usr=}} {{tp|p=32659343|t=2020. Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.|pdf=|usr=}} {{tp|p=32671793|t=2020. Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients.|pdf=|usr=}} {{tp|p=32651900|t=2020. SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology.|pdf=|usr=}} {{tp|p=32611518|t=2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.|pdf=|usr=}} {{tp|p=32704472|t=2020. Hemophagocytic syndrome and COVID-19.|pdf=|usr=}} {{tp|p=32664949|t=2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.|pdf=|usr=}} {{tp|p=32704018|t=2020. Human SARS-CoV-2 has evolved to reduce CG dinucleotide in its open reading frames.|pdf=|usr=}} {{tp|p=32691370|t=2020. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45(-) Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.|pdf=|usr=}} {{tp|p=32702413|t=2020. Multisystem Inflammatory Syndrome in Children: Is There a Linkage to Kawasaki Disease?|pdf=|usr=}} {{tp|p=32653566|t=2020. Understanding The Complex Relationship Between Androgens and SARS-CoV2.|pdf=|usr=}} {{tp|p=32679691|t=2020. Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes.|pdf=|usr=}} {{tp|p=32666230|t=2020. Germany's first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infection.|pdf=|usr=}} {{tp|p=32699972|t=2020. Mild Cytokine Elevation, Moderate CD4(+) T Cell Response and Abundant Antibody Production in Children with COVID-19.|pdf=|usr=}} {{tp|p=32687861|t=2020. Phylogenetic and phylodynamic analyses of SARS-CoV-2.|pdf=|usr=}} {{tp|p=32674515|t=2020. Validation of Variant Assembly Using HAPHPIPE with Next-Generation Sequence Data from Viruses.|pdf=|usr=}}
